Hosted in Boston in collaboration with the British Consulate, this event highlights groundbreaking strategies and partnerships accelerating healthcare advancements. Our team will discuss initiatives focusing on innovative treatment pathways and technological breakthroughs. From AI-driven diagnostics to next-generation therapies, the topics are designed to inspire transformative collaborations. Reach out to schedule a discussion with us and explore how our expertise aligns with your goals in innovation.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
